Literature DB >> 19698931

MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias.

Guido Marcucci1, Krzysztof Mrózek, Michael D Radmacher, Clara D Bloomfield, Carlo M Croce.   

Abstract

Altered expression of microRNAs, a new class of noncoding RNAs that regulate messenger RNA and protein expression of target genes, has been recently demonstrated to have an essential role in the process of leukaemogenesis. Distinctive patterns of activation and/or silencing of multiple microRNAs (microRNA signatures) associated with certain cytogenetic and molecular subsets of leukaemia have been identified using genome-wide high-throughput profiling assays. This has led not only to the discovery of new molecular pathways implicated in leukaemogenesis, but also supplied prognostic information complementing that gained from cytogenetics, gene mutations and altered gene expression in acute and chronic leukaemias. We review herein results of current studies analysing changes of microRNA expression in acute myeloid leukaemia and chronic lymphocytic leukaemia, and discuss their potential biologic, diagnostic and prognostic relevance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19698931     DOI: 10.1016/j.beha.2009.05.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  12 in total

1.  Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.

Authors:  Seyed H Ghaffari; Davood Bashash; Majid Zaki Dizaji; Ardeshir Ghavamzadeh; Kamran Alimoghaddam
Journal:  Tumour Biol       Date:  2011-11-10

2.  Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

Authors:  Sebastian Schwind; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Kelsi B Holland; Dean Margeson; Susan P Whitman; Christopher Hickey; Heiko Becker; Klaus H Metzeler; Peter Paschka; Claudia D Baldus; Shujun Liu; Ramiro Garzon; Bayard L Powell; Jonathan E Kolitz; Andrew J Carroll; Michael A Caligiuri; Richard A Larson; Guido Marcucci; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2010-11-15       Impact factor: 44.544

Review 3.  The prognostic and functional role of microRNAs in acute myeloid leukemia.

Authors:  Guido Marcucci; Krzysztof Mrózek; Michael D Radmacher; Ramiro Garzon; Clara D Bloomfield
Journal:  Blood       Date:  2010-11-02       Impact factor: 22.113

Review 4.  MicroRNA-146a and hemopoietic disorders.

Authors:  Zhong Hua; Wang Chun; Chen Fang-Yuan
Journal:  Int J Hematol       Date:  2011-09-08       Impact factor: 2.490

Review 5.  Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferations.

Authors:  Gerald B W Wertheim; Elizabeth Hexner; Adam Bagg
Journal:  Mol Diagn Ther       Date:  2012-12       Impact factor: 4.074

6.  IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

Authors:  Guido Marcucci; Kati Maharry; Yue-Zhong Wu; Michael D Radmacher; Krzysztof Mrózek; Dean Margeson; Kelsi B Holland; Susan P Whitman; Heiko Becker; Sebastian Schwind; Klaus H Metzeler; Bayard L Powell; Thomas H Carter; Jonathan E Kolitz; Meir Wetzler; Andrew J Carroll; Maria R Baer; Michael A Caligiuri; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2010-04-05       Impact factor: 50.717

7.  MicroRNA-155 hallmarks promising accuracy for the diagnosis of various carcinomas: results from a meta-analysis.

Authors:  Chuancheng Wu; Qiuyan Liu; Baoying Liu
Journal:  Dis Markers       Date:  2015-03-30       Impact factor: 3.434

Review 8.  Clinical significance of microRNAs in chronic and acute human leukemia.

Authors:  Chien-Hung Yeh; Ramona Moles; Christophe Nicot
Journal:  Mol Cancer       Date:  2016-05-14       Impact factor: 27.401

9.  Physiological Fitness and the Pathophysiology of Chronic Lymphocytic Leukemia (CLL).

Authors:  Andrea Sitlinger; Michael A Deal; Erwin Garcia; Dana K Thompson; Tiffany Stewart; Grace A MacDonald; Nicolas Devos; David Corcoran; Janet S Staats; Jennifer Enzor; Kent J Weinhold; Danielle M Brander; J Brice Weinberg; David B Bartlett
Journal:  Cells       Date:  2021-05-11       Impact factor: 6.600

10.  Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia.

Authors:  A M Dorrance; P Neviani; G J Ferenchak; X Huang; D Nicolet; K S Maharry; H G Ozer; P Hoellarbauer; J Khalife; E B Hill; M Yadav; B N Bolon; R J Lee; L J Lee; C M Croce; R Garzon; M A Caligiuri; C D Bloomfield; G Marcucci
Journal:  Leukemia       Date:  2015-06-09       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.